1Lee PY, Matchar DB, Clements DA, et al.Economic analysis of influenza vaccination and antiviral treatment for healthy working adults[J].Ann Intern Med, 2002, 137(4): 225.
3Adal KA, Flowers RH, Anglim AM, et al.Prevention of nosocomial influenza[J].Infect Control Hosp Epidemiol, 1996, 17: 641.
4Drinka PJ, Gravenstein S, Schilling M, et al.Duration of antiviral prophylaxis during nursing home outbreaks of influenza A[J].Arch Intern Med, 1998, 158: 2 155.
5Dolin R, Reichman RC, Madore HP, et al.A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection[J].N Engl J Med, 1982, 307 (10): 580.
6Clover RD, Crawford SA, Abell TD, et al.Effectiveness of rimantadine prophylaxis of children within families[J].Am of Diseases of Children, 1986, 140: 706.
7Hall CB, Dolin R, Gala CL, et al.Children with influen za A infection: Treatment with rimantadine[J].Pediatrics, 1987, 80(2): 275.
8Agarwal SB, Karavadara N, Khakhkhar V, et al.Bird flu: a diagnostic dilemma in the present scenario[J].Indian Academy of Clin Med, 2004, 5(4): 345.
9Webster RG, Kawaoka Y, Bean WJ.Vaccination as a strategy to reduce the emergence of amantadine-and rimantadine-resistant strains of A/Chick/Pennsylvania/83(H5N2)influenza virus[J].J Anti Chem, 1986, 18(Suppl B): 157.
10Zlydnikov DM.Study of Rimantadine in the USSR: A review of the literature[J].Reviews of Infectious Diseases, 1981, 3(3): 408.
